baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Vericel Corp/ US92346J1088 /

2024-05-08 9:59:59 PM	Chg. -1.86	Volume	Bid-	Ask-	High	Low
47.74USD	-3.75%	55,559 Turnover: 2.64 mill.	-Bid Size: -	-Ask Size: -	48.45	45.77

GlobeNewswire 05-08 Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

GlobeNewswire 04-24 Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

GlobeNewswire 02-29 Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Fina...

GlobeNewswire 02-27 Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

GlobeNewswire 02-15 Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

GlobeNewswire 02-05 Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

GlobeNewswire 01-09 Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

GlobeNewswire 01-09 MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include P...

GlobeNewswire 01-03 Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 20...

GlobeNewswire 2023-12-28 MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for...

GlobeNewswire 2023-11-21 MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update

GlobeNewswire 2023-11-08 Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

GlobeNewswire 2023-11-07 Vericel to Present at the Stephens Annual Investment Conference

GlobeNewswire 2023-10-25 Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

GlobeNewswire 2023-09-28 Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of...

GlobeNewswire 2023-09-21 MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Bu...

GlobeNewswire 2023-09-20 Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of S...

GlobeNewswire 2023-09-06 Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors

GlobeNewswire 2023-09-06 Vericel to Present at the Morgan Stanley Global Healthcare Conference

GlobeNewswire 2023-08-15 MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update

GlobeNewswire 2022-03-15 Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022

GlobeNewswire 2022-03-01 Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022

GlobeNewswire 2022-02-24 Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer

GlobeNewswire 2022-02-24 Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Fina...

GlobeNewswire 2022-02-10 MediWound Announces Additional $9 Million in Funding from BARDA to Support NexoBrid BLA Resubmission...

Vericel Corp/ US92346J1088 /

If you wish to receive reply to your feedback, please provide your email address.